06/05 | Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data | RE |
06/05 | Transcript : Moderna, Inc. - Special Call | CI |
06/05 | Merck & Co/Moderna Combo Cuts Risk of Melanoma Spreading in Mid-stage Study | MT |
06/05 | Cancer drugmakers rise as industry meet fuels investor interest | RE |
06/05 | Moderna, Merck Report Positive Results From Trial of mRNA-4157, Keytruda Combination to.. | MT |
06/05 | Insider Sell: Moderna | MT |
06/02 | Insider Sell: Moderna | MT |
06/02 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
06/02 | Analyst recommendations: AJ Bell, Dollar General, Quaker, Salesf.. | |
06/01 | US FDA approves Pfizer RSV vaccine a month after greenlighting GSK shot | RE |
06/01 | Lonza to Acquire Synaffix for Initial EUR100 Million | DJ |
06/01 | Lonza Group to Buy Biotechnology Company Synaffix | MT |
06/01 | Lonza Group AG acquired Synaffix BV. | CI |
05/31 | US FDA approves Pfizer's RSV vaccine | RE |
05/31 | Headwinds growing for Brenntag ahead of annual general meeting | DP |
05/31 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/30 | Sector Update: Health Care Stocks Slipping Late Tuesday | MT |
05/30 | Seagen Shareholders Approve Pfizer's Acquisition Deal | DJ |
05/30 | Galera Therapeutics Sues Alira Health Clinical, IQVIA Biotech Over Alleged Error for Dr.. | MT |
05/30 | Sector Update: Health Care Stocks Lower in Afternoon Trading | MT |
05/30 | Sector Update: Health Care | MT |
05/30 | Galera Therapeutics Sues Alira Health Clinical, IQVIA Biotech Over Alleged Error for Dr.. | MT |
05/30 | Moderna, Inc. acquired 149 Hayes Memorial Drive in Boston from Oxford Properties Group,.. | CI |
05/26 | Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines | RE |
05/26 | Sector Update: Health Care | MT |
05/26 | Shareholder advisor ISS opposes Brenntag candidate for supervisory board | DP |
05/26 | Moderna Registers Chinese Unit to Explore Prospects | MT |
05/26 | Dpa-AFX Overview: COMPANIES of 05/26/2023 - 3:15 p.m. | DP |
05/26 | Shareholder advisor ISS also opposes Brenntag candidate for supervisory board | DP |
05/25 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/24 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/24 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/24 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/23 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/23 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/23 | Somec wins two USD14 million orders in the US | AN |
05/20 | Alnylam Pharmaceuticals, Inc. Presents 18-Month Results from the Apollo-B Phase 3 Study.. | CI |
05/19 | Insider Sell: Moderna | MT |
05/19 | Moderna Sees 'Encouraging' Results From Phase 1/2 Trial of Investigational mRNA Therapy.. | MT |
05/19 | Catalent cuts annual revenue forecast hurt by operational challenges | RE |
05/19 | IQVIA Holdings Unit Prices Upsized $1.25 Billion Senior Notes Offering | MT |
05/18 | AlphaValue/Baader Europe Lowers Price Target on Lonza Group | MT |
05/17 | Global markets live: Target, Lyft, Pfizer, PayPal, Walt Disney... | |
05/17 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/17 | Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears | RE |
05/16 | Lonza Unit Prices EUR500 Million Bond | MT |
05/16 | Pfizer plans to raise $31 billion from debt offering to finance Seagen takeover | RE |
05/16 | Sector Update: Health Care Stocks Dropping Late Tuesday | MT |
05/16 | Sector Update: Health Care | MT |
05/16 | US FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics | RE |
05/16 | Pfizer Amends Terms on Bond Sale for Seagen Acquisition | MT |
05/16 | D'Amico, Irish subsidiary exercise purchase option on vessel | AN |
05/15 | Investor proposes two own candidates for Brenntag supervisory board seats | DP |
05/15 | Pfizer Investment Enterprises Launches Senior Notes Offering | MT |
05/12 | Insider Sell: Moderna | MT |
05/11 | Pfizer CEO calls US drug price plan 'negotiation with a gun to your head' | RE |
05/11 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/10 | Transcript : Alnylam Pharmaceuticals, Inc. Presents at Bank of America Securi.. | CI |
05/10 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/10 | Transcript : Lonza Group AG, Q1 2023 Earnings Call, May 10, 2023 | CI |
05/10 | Octavian Lifts Price Target on Lonza Group, Maintains Buy Recommendation | MT |
05/10 | D'Amico exercises option to purchase USD22 million MT High Trader | AN |
05/10 | Lonza Backs 2023 Outlook After In-Line 1Q | DJ |
05/10 | Lonza's Q1 Results Meets Expectations; Outlook Reiterated | MT |
05/10 | Tranche Update on Lonza Group AG's Equity Buyback Plan announced on January 25, 2023. | CI |
05/10 | Lonza Group AG Reiterates Sales Guidance for the Years 2023 | CI |
05/09 | IQVIA's Deal to Buy Propel Media Probed by Antitrust Watchdog | MT |
05/09 | Moderna COVID-19 Vaccine Authorized for Use in Children Aged 6 Months to 5 Years by UK .. | MT |
05/09 | Moderna's COVID-19 Vaccine Granted Authorization for Use in Children Aged 6 Months to 5.. | MT |
05/09 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/09 | UK Regulator Clears Moderna's COVID-19 Vaccine for Children Below Five Years Old | MT |
05/08 | Catalent shares tank on warning of $400 mln cut to annual revenue forecast | RE |
05/05 | Insider Sell: Moderna | MT |
05/05 | Declaration of Voting Results by Moderna Inc | CI |
05/05 | BMO Capital Upgrades Alnylam Pharmaceuticals to Outperform From Market Perform, Adjusts.. | MT |
05/05 | Lonza Group AG Approves Dividend for the year 2022, Payable Starting from 11 May 2023 | CI |
05/05 | Morgan Stanley Cuts Price Target on Moderna to $153 From $185, Maintains Equalweight Ra.. | MT |
05/05 | Analyst recommendations: Apple, Flutter, Kellogg, Tesla, Wesco.... | |
05/04 | Tranche Update on Moderna, Inc.'s Equity Buyback Plan announced on August 3, 2022. | CI |
05/04 | Sector Update: Health Care Stocks Slipping Late Thursday | MT |
05/04 | Sector Update: Health Care Stocks Dropping in Afternoon Trade | MT |
05/04 | Global markets live: Adecco, Qualcomm, Shell, Vodafone, Unilever... | |
05/04 | Moderna Posts Surprise First-Quarter Profit Despite COVID-19 Sales Plunge | MT |
05/04 | INTERVIEW - Stéphane Bancel, CEO of Moderna: cautio.. | MT |
05/04 | Transcript : IQVIA Holdings Inc. - Special Call | CI |
05/04 | Sector Update: Health Care Stocks Lean Lower Premarket Thursday | MT |
05/04 | Alnylam Pharmaceuticals Q1 Non-GAAP Net Loss Narrows, Revenue Rises; Reiterates 2023 Gu.. | MT |
05/04 | Earnings Flash (ALNY) ALNYLAM PHARMACEUTICALS Reports Q1 Revenue $319.3M, vs. Street Es.. | MT |
05/04 | PacWest Bancorp, Fed Rate Outlook in Focus Amid Mixed Premarket Exchange-Traded Funds, .. | MT |
05/04 | Earnings Flash (MRNA) MODERNATX Reports Q1 Revenue $1.9B, vs. Street Est of $1.166B | MT |
05/04 | Moderna's Q1 Earnings, Revenue Fall | MT |
05/04 | Transcript : Alnylam Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 04, 20.. | CI |
05/04 | Alnylam Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended Marc.. | CI |
05/04 | Alnylam Pharmaceuticals, Inc. Reiterates Earnings Guidance for the Full Year of 2023 | CI |
05/04 | Transcript : Moderna, Inc., Q1 2023 Earnings Call, May 04, 2023 | CI |
05/04 | Moderna beats COVID vaccine sales expectations as deferred revenue rolls in | RE |
05/04 | Moderna, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
05/04 | Insider Sell: Seagen | MT |
05/04 | Marketmind: Hike and hold, bank angst and Apple | RE |
05/04 | Shell sets USD4 billion buyback; Next backs outlook | AN |